CLINICAL_TRIALS
trial_result
· 2006-12-08
Clinical Trial Update: APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) for 10 Days in Patients With Strep Throat [Phase 3]
Summary
A Phase 3 trial comparing APC-111 administered once daily for 7 days to penicillin four times daily for 10 days in patients with strep throat has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Advancis Pharmaceutical Corporation | Conditions: Pharyngitis, Tonsillitis | Phase 3 | Status: COMPLETED